Redirecting to https://www.prnewswire.com/news-releases/egfr-inhibitors-market-to-witness-upsurge-in-growth-at-a-cagr-of-7-9-during-the-forecast-period-20262036-owing-to-the-entry-of-next-generation-tkis-adcs-and-combination-strategies-with-immunotherapy-delveinsight-302799978.html